Prof Emmanuel Gonzales is an expert in Hepatology at Bicêtre Hospital (France). As of October 2026, ScienceLeadR ranks Emmanuel Gonzales in the top 1% of experts worldwide for Cholestasis, Bile Duct Diseases and Biliary Tract Diseases. Emmanuel Gonzales has authored 188 publications, the most recent in 2026, and is an investigator in 9 clinical trials, 2 of them ongoing. SLR score: 757 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Emmanuel Gonzales Bicêtre Hospital France
757 ScienceLeadR Reputation 757
Network Map

Hepatology

Subspecialties: Gastroenterology - Pediatrics - Transplantation

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2007 - 2026

Source: PubMed

Bicêtre Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 188

Citations

Citations: 4 243 1st author: 25 Last author: 23 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Immunization and the hepatitis B virus: A view from the ESPGHAN Hepatology Committee.
PMID 42670276 — immunization, hepatitis b virus, vaccines, autistic disorder, vaccination, herpesvirus 1, cercopithecine, viruses, centers for disease control and prevention, u.s., hepatitis b, infections, hepatitis, infant
J Pediatr Gastroenterol Nutr20260
Long-term follow-up, complications and outcomes of Meso-Rex bypass for extrahepatic portal vein obstruction (EHPVO): a systematic review.
PMID 42509118 — hemorrhage, portal vein, veins
Dig Liver Dis20260
Post-transplant alloimmune liver disease in bile salt export pump deficiency: A multicenter study.
PMID 42501969 — liver diseases, liver transplantation, bile, antibodies, plasmapheresis, liver, rituximab, atp binding cassette transporter, subfamily b, member 11, genotype, transplants, therapeutics, transplantation
JHEP Rep20260
Adulthood outcomes of patients with biliary atresia living with their native liver.
PMID 41956010 — liver, biliary atresia, pediatrics
Arch Pediatr20260
Echocardiography, Bile Acids and Spleen Stiffness to Rule Out High-Risk Varices in Children With Biliary Atresia.
PMID 41934119 — hypertension, bile, hemorrhage, serum, elasticity imaging techniques, liver, endoscopy, hypertension, portal, echocardiography, biliary atresia, spleen, varicose veins, child
Liver Int20260

Clinical Studies 9

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 3 5
N/A 2
Phase 2 1
Phase 4 1

By status:

Completed 6
Active not recruiting 1
Recruiting 1
Unknown 1

By type:

Interventional 8
Observational 1

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 1
multicentricup10 6

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Randomized Double Blind Placebo Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Maralixibat in the Treatment of Participants with Cholestatic Pruritus
2024-511287-85-00 — safety, pruritus, therapeutics
Phase 3Active not recruiting2025
Long Term Low Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli in Patients With Alagille Syndrome or Progressive Familial Intrahepatic Cholestasis in the European Union (LEAP EU)
NCT07290257 — liver diseases, cholestasis, alagille syndrome, safety, cholestasis, intrahepatic, liver, pruritus, european union
Phase 4Recruiting2025

LeadR Networks

Main global connection map